Lower riskMedical device recall · FDA · Published February 28, 2022
Integra Universal Flexible Arm Recall: Cable Break Risk from Excess Tightening
Integra recalls Universal Flexible Arm part REF 1362275 due to cable breakage from excessive tightening. Affected units include specific lots and UDI numbers. No remedy provided in official notice.
“Integra Universal Flexible Arm Recall: Cable Break Risk from Excess Tightening.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61020-integra-universal-flexible-arm-recall-cable-break-risk-from-excess. Based on FDA recall #Z-0906-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0906-2022%22&limit=1).
Integra LifeSciences Corp. recalled Integra Universal Flexible Arm part number REF 1362275 due to a hazard where excess force can break the internal cable, according to the FDA on Feb. 28, 2022.
Distribution: US Nationwide (AL, AZ, FL, GA, IL, MA, MD, NY, OH, OR, PA, TX)
The hazard
Excess force used to tighten the Universal Flexible Arm can cause the internal cable to break at the tip, resulting in an unusable condition.
Context
GovInfoNow's records show Integra LifeSciences Corp. has 35 other recalls on record since Aug. 18, 2017. Recent similar product recalls include Aju Pharm Genesis Dual Thread Screw-In Anchor Recall (Dec. 17, 2025), Fixone Hybrid Anchor Recall (Dec. 17, 2025), and Aju Pharm AlternatiV+ Screw-In Anchor Recall (Dec. 17, 2025).
How to tell if you have this one
Check if your Universal Flexible Arm has part number REF 1362275 and UDI number 10381780074670. Affected units include production lots AC2109, AC2103, AC2106, AC2110, AC2101, AC2008, and AC2009.
Brand
Integra
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify your Universal Flexible Arm has part number REF 1362275 and UDI number 10381780074670.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 12 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide Distribution: AL, AZ, FL, GA, IL, MA, MD, NY, OH, OR, PA, TX” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, Florida, Georgia, Illinois, Maryland, Massachusetts, New York, Ohio, Oregon, Pennsylvania, Texas.
Recall timeline
FDA published this recall 51 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0906-2022 (February 28, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0906-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.